Robin Anderson is a Professor in the School of Cancer Medicine and Head of the Translational Breast Cancer Program and Head of the Metastasis Research Laboratory based at the Olivia Newton-John Cancer Research Institute (ONJCRI). Her research focuses on the genetic regulation of metastasis, the major cause of death in patients with solid cancers. She utilises preclinical models of breast cancer metastasis and clinical samples to identify new targets for molecular based therapy for patients with progressive disease.

Robin completed her PhD at La Trobe University before gaining postdoctoral training at Stanford University, California and at the MRC in London. Prior to joining ONJCRI and La Trobe in 2016, she was a Group Leader at the Peter MacCallum Cancer Centre, where she first developed the models of breast cancer metastasis that have allowed identification of genes that control metastasis. She has a particular interest in targeting genes in the tumour microenvironment, in host fibroblasts and immune cells, that regulate the process of metastasis to specific organs such as bone, liver, lung and brain. These preclinical models are also used for trialling novel anti-metastatic agents, often in collaboration with pharmaceutical companies.